Prime Medicine's application will test an FDA that has promised to speed new gene-editing treatments but has recently spurned ...
Rapid advancements in CRISPR and next-generation gene editing technologies, combined with a strong clinical pipeline ...
After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...
CRISPR gene editing has transitioned from a laboratory curiosity to a cornerstone of modern biotechnology, revolutionizing our approach to genetic diseases, including Charcot-Marie-Tooth (CMT) disease ...
New gene editing techniques, like adenine base editing and prime editing, are creating new possibilities for treating dilated cardiomyopathy, a heart condition affecting about 1 in 250 people ...
Volatile macroeconomic events are magnified in life science and healthcare applications, which are capital intensive, long-term investments with associated regulatory, safety, and commercial risks.
SOMERVILLE, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced that the U.S.
LEXINGTON, Ky.--(BUSINESS WIRE)--Demeetra, a gene editing technologies company, is proud to announce that its research in collaboration with Variation Biosciences, Inc. “VBI” has been selected for an ...
Gene editing refers to the precise alteration of an organism's DNA sequence at a specific locus. In cancer treatment, this technology is leveraged to modify the genetic makeup of cancer cells, either ...
Gene therapy and gene editing are marvels of modern biotechnology, providing revolutionary techniques for fixing genetic abnormalities. Gene therapy introduces functional genetic material to ...
Consumers are far more open to gene-edited foods when the benefits are personal, values-driven and clearly explained, according to recent research from The Center for Food Integrity (CFI) and FMI – ...